Additionally, CCT2 was expressed in all cell types in the human brain (Figure 4G) and significantly downregulated in various brain regions (Figure 4H), indicating that CCT2 and its related genes are significantly correlated with AD and have broad prospects as a biomarker. This evidence concerns the gene CCT2 and Alzheimer disease.